Cargando…
A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres
BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies compari...
Autores principales: | , , , , , , , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Wolters Kluwer Health, Inc.
2023
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431334/ https://www.ncbi.nlm.nih.gov/pubmed/37600875 http://dx.doi.org/10.1097/AS9.0000000000000263 |
_version_ | 1785091176504754176 |
---|---|
author | Smalbroek, Bo Geitenbeek, Ritchie Burghgraef, Thijs Dijksman, Lea Hol, Jeroen Rutgers, Marieke Crolla, Rogier van Geloven, Nanette Leijtens, Jeroen Polat, Fatih Pronk, Apollo Verdaasdonk, Emiel Tuynman, Jurriaan Sietses, Colin Postma, Maarten Hompes, Roel Consten, Esther Smits, Anke |
author_facet | Smalbroek, Bo Geitenbeek, Ritchie Burghgraef, Thijs Dijksman, Lea Hol, Jeroen Rutgers, Marieke Crolla, Rogier van Geloven, Nanette Leijtens, Jeroen Polat, Fatih Pronk, Apollo Verdaasdonk, Emiel Tuynman, Jurriaan Sietses, Colin Postma, Maarten Hompes, Roel Consten, Esther Smits, Anke |
author_sort | Smalbroek, Bo |
collection | PubMed |
description | BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview. METHOD: This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis. RESULTS: In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively (P < 0.001). Also, the one-team transanal approach showed significant higher operation time and higher costs compared to the two-team approach. Length of stay and postoperative complications did not differ between groups. CONCLUSION: Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach. |
format | Online Article Text |
id | pubmed-10431334 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2023 |
publisher | Wolters Kluwer Health, Inc. |
record_format | MEDLINE/PubMed |
spelling | pubmed-104313342023-08-18 A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres Smalbroek, Bo Geitenbeek, Ritchie Burghgraef, Thijs Dijksman, Lea Hol, Jeroen Rutgers, Marieke Crolla, Rogier van Geloven, Nanette Leijtens, Jeroen Polat, Fatih Pronk, Apollo Verdaasdonk, Emiel Tuynman, Jurriaan Sietses, Colin Postma, Maarten Hompes, Roel Consten, Esther Smits, Anke Ann Surg Open Original Study BACKGROUND: Total mesorectal excision has been the gold standard for the operative management of rectal cancer. The most frequently used minimally invasive techniques for surgical resection of rectal cancer are laparoscopic, robot-assisted, and transanal total mesorectal excision. As studies comparing the costs of the techniques are lacking, this study aims to provide a cost overview. METHOD: This retrospective cohort study included patients who underwent total mesorectal resection between 2015 and 2017 at 11 dedicated centers, which completed the learning curve of the specific technique. The primary outcome was total in-hospital costs of each technique up to 30 days after surgery including all major surgical cost drivers, while taking into account different team approaches in the transanal approach. Secondary outcomes were hospitalization and complication rates. Statistical analysis was performed using multivariable linear regression analysis. RESULTS: In total, 949 patients were included, consisting of 446 laparoscopic (47%), 306 (32%) robot-assisted, and 197 (21%) transanal total mesorectal excisions. Total costs were significantly higher for transanal and robot-assisted techniques compared to the laparoscopic technique, with median (interquartile range) for laparoscopic, robot-assisted, and transanal at €10,556 (8,642;13,829), €12,918 (11,196;16,223), and € 13,052 (11,330;16,358), respectively (P < 0.001). Also, the one-team transanal approach showed significant higher operation time and higher costs compared to the two-team approach. Length of stay and postoperative complications did not differ between groups. CONCLUSION: Transanal and robot-assisted approaches show higher costs during 30-day follow-up compared to laparoscopy with comparable short-term clinical outcomes. Two-team transanal approach is associated with lower total costs compared to the transanal one-team approach. Wolters Kluwer Health, Inc. 2023-03-07 /pmc/articles/PMC10431334/ /pubmed/37600875 http://dx.doi.org/10.1097/AS9.0000000000000263 Text en Copyright © 2023 The Author(s). Published by Wolters Kluwer Health, Inc. https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open-access article distributed under the terms of the Creative Commons Attribution-Non Commercial-No Derivatives License 4.0 (CCBY-NC-ND) (https://creativecommons.org/licenses/by-nc-nd/4.0/) , where it is permissible to download and share the work provided it is properly cited. The work cannot be changed in any way or used commercially without permission from the journal. |
spellingShingle | Original Study Smalbroek, Bo Geitenbeek, Ritchie Burghgraef, Thijs Dijksman, Lea Hol, Jeroen Rutgers, Marieke Crolla, Rogier van Geloven, Nanette Leijtens, Jeroen Polat, Fatih Pronk, Apollo Verdaasdonk, Emiel Tuynman, Jurriaan Sietses, Colin Postma, Maarten Hompes, Roel Consten, Esther Smits, Anke A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title | A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title_full | A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title_fullStr | A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title_full_unstemmed | A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title_short | A Cost Overview of Minimally Invasive Total Mesorectal Excision in Rectal Cancer Patients: A Population-based Cohort in Experienced Centres |
title_sort | cost overview of minimally invasive total mesorectal excision in rectal cancer patients: a population-based cohort in experienced centres |
topic | Original Study |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10431334/ https://www.ncbi.nlm.nih.gov/pubmed/37600875 http://dx.doi.org/10.1097/AS9.0000000000000263 |
work_keys_str_mv | AT smalbroekbo acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT geitenbeekritchie acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT burghgraefthijs acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT dijksmanlea acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT holjeroen acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT rutgersmarieke acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT crollarogier acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT vangelovennanette acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT leijtensjeroen acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT polatfatih acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT pronkapollo acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT verdaasdonkemiel acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT tuynmanjurriaan acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT sietsescolin acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT postmamaarten acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT hompesroel acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT constenesther acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT smitsanke acostoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT smalbroekbo costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT geitenbeekritchie costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT burghgraefthijs costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT dijksmanlea costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT holjeroen costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT rutgersmarieke costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT crollarogier costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT vangelovennanette costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT leijtensjeroen costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT polatfatih costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT pronkapollo costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT verdaasdonkemiel costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT tuynmanjurriaan costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT sietsescolin costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT postmamaarten costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT hompesroel costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT constenesther costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres AT smitsanke costoverviewofminimallyinvasivetotalmesorectalexcisioninrectalcancerpatientsapopulationbasedcohortinexperiencedcentres |